WHAT LEGAL STRUCTURE FOR HEALTH PRODUCT ASSESSMENT AUTHORITIES?

Abstract

In France, the highly sensitive issues surrounding the evaluation of healthcare products are placed in the hands of two bodies. The HAS, characterized as an independent public scientific authority, evaluates healthcare technologies in order to guide the reimbursement of costs by the national health system. The ANSM, a public body under government supervision, assesses the benefits and risks of healthcare products. This contribution questions the legal distinction between these two bodies, and raises the idea of bringing them together to form a public health product expertise center to meet the new challenges facing this sector.